Introduction to 2016 Wmif Creating A Disruptive Cancer Pipeline
Exploring 2016 Wmif Creating A Disruptive Cancer Pipeline reveals several interesting facts. Moderator: Robert Tepper, MD, Partner, Third Rock Ventures, Adjunct Professor, Harvard Medical School James Bradner, MD, ...
2016 Wmif Creating A Disruptive Cancer Pipeline Comprehensive Overview
Moderator: Nir Hacohen, PhD, Immunologist, MGH Center for Immunology and Inflammatory Diseases, MGH Research Scholar, ... Moderator: David Louis, MD, Pathologist-in-Chief, MGH, Benjamin Castleman Professor of Pathology, Harvard Medical School ... Moderator: Sheila Dharmarajan, Head of Business Development, Zelnick Media Capital Newton Crenshaw, Vice President of ...
Moderator: Nancy Snyderman, MD, Medical Advisor, GE Healthymagination Monica Bertagnolli, MD, Chief, Division of Surgical ...
Summary & Highlights for 2016 Wmif Creating A Disruptive Cancer Pipeline
- Moderator: Sue Siegel, CEO, GE Ventures and Healthymagination Troyen Brennan, MD, Executive Vice President and CMO, CVS ...
- Moderator: Jens Eckstein, PhD, President, SR One Kenneth Anderson, MD, Director, Jerome Lipper Multiple Myeloma Center, ...
- 'Study Designs to Meet the Challenges of Personalized
- Moderator: Thomas Lynch, MD, CEO, Mass General Physician's Organization Francis Cuss, MD, Executive Vice President and ...
- Moderator: David Fisher, MD, PhD, Chief, Dermatology Service, Director, Melanoma Program, Director, Cutaneous Biology ...
Stay tuned for more updates related to 2016 Wmif Creating A Disruptive Cancer Pipeline.
